Stem cell regs to become law?

US President Barack Obama's 2009 executive order to allow the federal funding of research using new human embryonic stem cell (hESC) lines may become law. Human embryonic stem cellsImage: Wikimedia commons, Nissim BenvenistyYesterday (March 9), on the one-year anniversary of Obama's announcement, members of Congress Diana DeGette of Colorado and Mike Castle of Delaware reintroduced the Stem Cell Research Advancement Act to "ensure a lasting ethical framework" for such research. DeGette and Cas

Written byJef Akst
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
US President Barack Obama's 2009 executive order to allow the federal funding of research using new human embryonic stem cell (hESC) lines may become law.
Human embryonic stem cells
Image: Wikimedia commons,
Nissim Benvenisty
Yesterday (March 9), on the one-year anniversary of Obama's announcement, members of Congress Diana DeGette of Colorado and Mike Castle of Delaware reintroduced the Stem Cell Research Advancement Act to "ensure a lasting ethical framework" for such research. DeGette and Castle were the lead sponsors of the bill when it was introduced during the tenure of former President George W. Bush, who vetoed it twice. The legislation would codify Obama's executive order, which overturned the limitations implemented by Bush, and made it possible for scientists to use federal funds to study hESCs derived after August 9, 2001. So far, the National Institutes of Health (NIH) have approved a total of 43 lines, more than double the lines available for distribution during the Bush administration. The new bill builds on the NIH guidelines introduced last summer for approving hESC lines for federal fudning, and requires that the NIH review and update the guidelines at least every three years, as well as submit a biennial report to Congress on the research. "Congress must still enact legislation so that both scientists and individuals who stand to benefit from the promise of this research will have some stability backing their quest for life-changing cures," DeGette said linkurl:in a statement.;http://www.castle.house.gov/News/DocumentSingle.aspx?DocumentID=175218
**__Related stories:__***linkurl:27 more hESC lines approved;http://www.the-scientist.com/blog/display/56219/
[15th December 2009 ]*linkurl:NIH OKs 13 stem cell lines;http://www.the-scientist.com/blog/display/56196/
[2nd December 2009]*linkurl:NIH loosens stem cell consent rules;http://www.the-scientist.com/blog/display/55814/
[6th July 2009]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform